UNSPSC 51162400: Combination decongestants, with analgesics, antitussives, or expectorants

This classification denotes combination drugs and preparations that treat inflammation of the nasal passages, generally the result of an infection (such as the common cold) or an allergy related condition, and which thereby relieve nasal congestion, hence the term DECONGESTANTS; b) combination drugs and preparations that relieve pain without the loss of consciousness, hence the term ANALGESICS; c) combination drugs containing preparations that suppress cough, hence the term ANTITUSSIVES; and/or d) combination drugs containing preparations that increase mucous excretion, hence the term EXPECTORANTS.

Typical combination decongestant, with analgesic, antitussive, or expectorant constituents are acetaminophen, caramiphen, dextromethorphan, ephedrine, guaifenesin, and phenylephrine.

UNSPSC 51162400 Combination decongestants, with analgesics, antitussives, or expectorants is a Class code that shows limited alignment between its nominal scope and current state and local procurement activity. The recent opportunities tagged under this code reflect purchases of parenteral products, naloxone, and drug deactivation systems—pharmaceutical and medical-supply categories that fall outside the code's stated focus on oral combination decongestant formulations. The Washington State Department of Corrections (DOC) and Seminole County, Florida are the issuing bodies appearing in recent records, representing a correctional health system and county public health function, respectively. Neither opportunity reflects active procurement of combination decongestants as the code nominally describes them.

The Washington State DOC issued RFQ RFQQK13020 on September 8, 2026, with a response deadline of October 7, 2026, seeking parenteral products and services—primarily parenteral nutrition solutions, intravenous solutions, and controlled substances for eight correctional facilities across three regions (West, Central, and East). Seminole County, Florida posted IFB 60459723LAS in June 2026 for naloxone and drug deactivation systems with annual volumes of 1,900 units and 800 units respectively, delivered quarterly to the Seminole County Community Health Building. Both opportunities target state and local health-related spending but represent pharmaceutical procurement outside the scope of oral combination decongestants. The code shows little recent relevant activity in its actual commodity category; buyers evaluating this code should verify whether state and local procurement offices have migrated related solicitations to more accurate UNSPSC classifications or whether the code receives minimal use for its intended product family.